|
⚲
|
| Keyboard |
| Lexaria Bioscience Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001348362 |
| Sale | 2026-09-09 (0.1 M Offered, 0.1 M Sold) |
| Fund | |
| Phone | 2507656424 |
| Address | 100 740 Mccurdy Road Kelowna, A1 V1X 2P7 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-09-21 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Commission | $7,944 |
| Revenue | $5,000,001 - $25,000,000 |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Bal Bhullar | Director | |
| Albert Reese | Director | |
| William McKechnie | Director | |
| Nicholas Baxter | Director | |
| Michael Shankman | Executive Officer | |
| Richard Christopher | Executive Officer | |
| John Docherty | Executive Officer | |
| Christopher Bunka | Director |
| Comparable Firms | State | AUM |
|---|---|---|
|
Genus Capital Management Inc
✚
|
A1 | |
|
British Columbia Investment Management Corp
✚
|
A1 | |
|
Pacad Investment Ltd
✚
|
A1 | |
|
McLean Budden Ltd
✚
|
A1 | |
|
Dixon Mitchell Investment Counsel Inc
✚
|
A1 | |
|
Asia Pacific Associates III Ltd
✚
|
A1 | |
|
JPMorgan Asset Management Canada Inc
✚
|
A1 | |
|
PenderFund Capital Management Ltd
✚
|
A1 | |
|
HSBC Global Asset Management Canada LTD
✚
|
A1 | |
|
North Growth Management Ltd
✚
|
A1 |